Skip Navigation


BJA Advance Access originally published online on May 16, 2008
British Journal of Anaesthesia 2008 101(1):111-120; doi:10.1093/bja/aen090
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
101/1/111    most recent
aen090v1
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Karp, J. F.
Right arrow Articles by Weiner, D. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karp, J. F.
Right arrow Articles by Weiner, D. K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Board of Management and Trustees of the British Journal of Anaesthesia 2008. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Advances in understanding the mechanisms and management of persistent pain in older adults{dagger}

J. F. Karp1,2,{ddagger}, J. W. Shega5, N. E. Morone3 and D. K. Weiner1,2,3,4,*

1 Department of Psychiatry
2 Department of Anesthesiology
3 Department of Medicine, University of Pittsburg School of Medicine
4 Geriatric Research Education and Clinical Center, VA Pittsburgh Healthcare System, Pittsburgh, USA
5 Department of Medicine at Northwestern University School of Medicine, USA

* Corresponding author. E-mail: weinerdk{at}upmc.edu

Older adults with persistent pain are not simply a chronologically older version of younger pain patients. Pain-related disability in older adults may be driven by pain ‘homeostenosis’, that is, diminished ability to effectively respond to the stress of persistent pain. Some of the comorbidities of ageing that can contribute to pain homeostenosis include cognitive and physical impairments, increased sensitivity to suprathreshold pain stimuli, medical and psychological comorbidities, altered pharmacokinetics and pharmacodynamics, and social isolation. A key distinction between older and younger individuals with persistent pain is the normal and pathological ageing-associated brain changes. These may alter the expression and experience of pain with impaired descending inhibition and dysfunction of pain gating mechanisms. Cognizance of these brain changes is needed to guide appropriate evaluation and treatment approaches. This paper reviews data that support these ageing-associated phenomena. Specifically, we discuss age-related changes in the brain (both normal and pathological) and in pain physiology; changes in experience and expression of pain that occur with dementia and contribute to pain homeostenosis; and unique aspects of age and pain-associated psychological function and their contribution to disability. We also present data demonstrating changes in brain morphology and neuropsychological performance that accompany persistent non-malignant pain in older adults and the treatment implications of these brain changes. Finally, preliminary data are presented on the efficacy of mindfulness meditation, a treatment that has been examined explicitly in older adults and targets optimizing brain function and descending inhibition.

Keywords: age factors; pain; chronic; stress


{dagger} This article's contents are solely the responsibility of the authors and do not necessarily represent the official view of the National Center for Research Resources (NCRR) or the National Institutes of Health (NIH). Information on NCRR is available at http://www.ncrr.nih.gov/. Information on Re-engineering the Clinical Research Enterprise can be obtained from http://nihroadmap.nih.gov/clinicalresearch/overview-translational.asp.

{ddagger} Declaration of interest. Dr Karp is an advisor for Eli Lily and Myriad Pharmaceuticals. He also received medication supplies for an investigator-initiated trial from Eli Lily and is a stockholder of Corcept.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
R. Canovas, I. Leon, M. D. Roldan, R. Astur, and J. M. Cimadevilla
Virtual reality tasks disclose spatial memory alterations in fibromyalgia
Rheumatology, October 1, 2009; 48(10): 1273 - 1278.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
L. A. Colvin and D. G. Lambert
Pain medicine: advances in basic sciences and clinical practice
Br. J. Anaesth., July 1, 2008; 101(1): 1 - 4.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.